Begum N, Tepperman H M, Tepperman J
Endocrinology. 1984 Jan;114(1):99-107. doi: 10.1210/endo-114-1-99.
Rats were treated with dexamethasone (50 micrograms/day, sc) for 4 days. Total pyruvate dehydrogenase (PDH) and insulin-stimulated PDHa activities were decreased in fat pads from dexamethasone-treated rats compared to control values. Coincubation experiments with adipocyte mitochondria, plasma membrane, and insulin demonstrated decreased stimulation of PDH in preparations from dexamethasone-treated rats. The responsiveness of the mitochondrial PDH system to insulin and control rat plasma membranes was not different in glucocorticoid-treated adipocyte preparations compared to controls. Liver mitochondria from dexamethasone-treated rats demonstrated decreased basal enzyme activity and a decreased percentage of stimulation of PDH when supernatants from insulin-exposed liver particulate fractions were tested. These experiments suggest that insulin resistance produced by glucocorticoid treatment, like that resulting from fat feeding, is accompanied by a decrease in the capacity of adipocyte and liver plasma membranes to generate PDH activator in response to insulin.
大鼠接受地塞米松(50微克/天,皮下注射)处理4天。与对照值相比,地塞米松处理的大鼠脂肪垫中总丙酮酸脱氢酶(PDH)和胰岛素刺激的PDHa活性降低。用脂肪细胞线粒体、质膜和胰岛素进行的共孵育实验表明,地塞米松处理的大鼠制备物中PDH的刺激作用降低。与对照相比,糖皮质激素处理的脂肪细胞制备物中线粒体PDH系统对胰岛素和对照大鼠质膜的反应性没有差异。当测试胰岛素暴露的肝脏微粒体部分的上清液时,地塞米松处理的大鼠肝脏线粒体显示基础酶活性降低,PDH刺激百分比降低。这些实验表明,糖皮质激素处理产生的胰岛素抵抗,与脂肪喂养产生的胰岛素抵抗一样,伴随着脂肪细胞和肝脏质膜响应胰岛素产生PDH激活剂的能力下降。